NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
03/10/2026
Back to search
Official data from USPTO
JP JAZZ PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
03/11/2026
Trademark type
Combined
Nice classes
5
Filing date
12/10/2018
Registration date
12/17/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2026
Last transaction
03/11/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
09/08/2004
First use in commerce
09/08/2004
Drawing code
3
Owner type
03
Owner location
Palo Alto, CA, US
Examiner
LEE, JEANIE H
Current location
Historical data usage
Mark description
The mark consists of "JAZZ PHARMACEUTICALS" positioned to the right of a circular logo with a stylized depiction of the letters "JP" which vertically splits the circle.
Holders and representatives
Holders
Jazz Pharmaceuticals, Inc.
Representatives
Michael Olsen Winthrop & Weinstine, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
House mark for a line of pharmaceuticals for the treatmentmanagement and prevention of cancerpsychiatric diseases and disorderscentral nervous system conditionssleep disordersnarcolepsyschizophreniacataplexyobstructive sleep apneafor use in oncological and hematological diseases and disorders; Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment and management of neurologicalpsychiatricsleep conditionsdiseasesdisorders; pharmaceutical preparations for the treatment and management of cancercataplexyexcessive daytime sleepinessliver diseasenarcolepsyobstructive sleep apneaschizophrenia
Publications
History of USPTO decisions and trademark events.
35 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/18/2026
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/18/2026
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
02/18/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/13/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
11/11/2025
E815
TEAS SECTION 8 & 15 RECEIVED
11/11/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/17/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2019
PUBO
PUBLISHED FOR OPPOSITION
10/01/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/15/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/15/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/25/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/25/2019
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
03/15/2019
ALIE
ASSIGNED TO LIE
03/15/2019
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/14/2019
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/14/2019
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
03/14/2019
DOCK
ASSIGNED TO EXAMINER
03/07/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/02/2019
NWAP
NEW APPLICATION ENTERED
12/13/2018
Continuous trademark protection
Get notified about every new filing that threatens JP JAZZ PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.